Sumatriptan/naproxen sodium
Jump to navigation
Jump to search
| Combination of | |
|---|---|
| Sumatriptan | Triptan |
| Naproxen sodium | NSAID |
| Clinical data | |
| Trade names | Treximet, Trexima, others |
| Routes of administration | By mouth |
| Identifiers | |
| KEGG | |
Sumatriptan/naproxen sodium, sold under the brand name Treximet, is a combination medication used to treat migraines attacks.[1] It is taken by mouth.[1]
In the United States the combination costs about 50 USD per dose.[2] By themselves a dose of sumatriptan costs about 0.60 USD while a dose of naproxen is about 0.18 USD.[2]
Active ingredients[edit]
It combines 85 mg of sumatriptan, a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist and 500 mg of naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs), in one tablet.
Side effects[edit]
Some of the listed side effects include dizziness, nausea, sleepiness, dry mouth, pain in neck, throat or jaw, numbness or tingling.[3]
References[edit]
- ^ a b "DailyMed - sumatriptan succinate and naproxen sodium tablet, film coated". dailymed.nlm.nih.gov. Retrieved 6 March 2019.
- ^ a b "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
- ^ https://www.drugs.com/treximet.html
External links[edit]
| Subsidiaries | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||||
| Products |
| ||||||||||
| People |
| ||||||||||
| Litigation | |||||||||||
| Other | |||||||||||
